Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results
Background: Levodopa-carbidopa intestinal gel (LCIG) improves motor and non-motor symptoms in patients with advanced Parkinson’s disease (aPD). Objective: To present the final 36-month efficacy and safety results from DUOGLOBE (DUOdopa/Duopa in Patients with Advanced Parkinson’s Disease – a GLobal O...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publishing
2023-07-01
|
| 叢編: | Journal of Parkinson’s Disease |
| 在線閱讀: | https://doi.org/10.3233/JPD-225105 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
